NZ606232A - Single-stranded nucleic acid molecule for controlling gene expression - Google Patents

Single-stranded nucleic acid molecule for controlling gene expression

Info

Publication number
NZ606232A
NZ606232A NZ606232A NZ60623211A NZ606232A NZ 606232 A NZ606232 A NZ 606232A NZ 606232 A NZ606232 A NZ 606232A NZ 60623211 A NZ60623211 A NZ 60623211A NZ 606232 A NZ606232 A NZ 606232A
Authority
NZ
New Zealand
Prior art keywords
region
side region
bases
acid molecule
nucleic acid
Prior art date
Application number
NZ606232A
Other languages
English (en)
Inventor
Tadaaki Ohgi
Hirotake Hayashi
Hisao Shirohzu
Tomohiro Hamasaki
Akihiro Itoh
Hiroshi Suzuki
Original Assignee
Bonac Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bonac Corp filed Critical Bonac Corp
Priority to NZ704812A priority Critical patent/NZ704812A/en
Publication of NZ606232A publication Critical patent/NZ606232A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/318—Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/533—Physical structure partially self-complementary or closed having a mismatch or nick in at least one of the strands

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ606232A 2010-07-08 2011-07-08 Single-stranded nucleic acid molecule for controlling gene expression NZ606232A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ704812A NZ704812A (en) 2010-07-08 2011-07-08 Single-stranded nucleic acid molecule for controlling gene expression

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2010156122 2010-07-08
JP2010174915 2010-08-03
JP2010230806 2010-10-13
JP2010230808 2010-10-13
JP2010269824 2010-12-02
JP2010269823 2010-12-02
PCT/JP2011/065737 WO2012005368A1 (ja) 2010-07-08 2011-07-08 遺伝子発現制御のための一本鎖核酸分子

Publications (1)

Publication Number Publication Date
NZ606232A true NZ606232A (en) 2015-06-26

Family

ID=45441339

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ704812A NZ704812A (en) 2010-07-08 2011-07-08 Single-stranded nucleic acid molecule for controlling gene expression
NZ606232A NZ606232A (en) 2010-07-08 2011-07-08 Single-stranded nucleic acid molecule for controlling gene expression

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NZ704812A NZ704812A (en) 2010-07-08 2011-07-08 Single-stranded nucleic acid molecule for controlling gene expression

Country Status (17)

Country Link
EP (2) EP2933333B1 (cg-RX-API-DMAC7.html)
JP (3) JP4968811B2 (cg-RX-API-DMAC7.html)
KR (1) KR101849798B1 (cg-RX-API-DMAC7.html)
CN (2) CN102918156B (cg-RX-API-DMAC7.html)
AU (1) AU2011274854B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013000481A2 (cg-RX-API-DMAC7.html)
CA (1) CA2804511C (cg-RX-API-DMAC7.html)
DK (2) DK2431466T3 (cg-RX-API-DMAC7.html)
ES (2) ES2670017T3 (cg-RX-API-DMAC7.html)
HU (2) HUE026520T2 (cg-RX-API-DMAC7.html)
MX (1) MX352568B (cg-RX-API-DMAC7.html)
NZ (2) NZ704812A (cg-RX-API-DMAC7.html)
PT (2) PT2933333T (cg-RX-API-DMAC7.html)
RU (1) RU2628311C2 (cg-RX-API-DMAC7.html)
SG (2) SG186899A1 (cg-RX-API-DMAC7.html)
TW (2) TWI573870B (cg-RX-API-DMAC7.html)
WO (1) WO2012005368A1 (cg-RX-API-DMAC7.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8691782B2 (en) 2010-08-03 2014-04-08 Bonac Corporation Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
WO2013077446A1 (ja) * 2011-11-26 2013-05-30 株式会社ボナック 遺伝子発現制御のための一本鎖核酸分子
WO2013133393A1 (ja) * 2012-03-07 2013-09-12 学校法人東京医科大学 Ｖｅｇｆ遺伝子の発現抑制用一本鎖核酸分子
TW201343668A (zh) 2012-03-29 2013-11-01 Univ Kyushu Nat Univ Corp 成骨細胞特異因子（ｐｅｒｉｏｓｔｉｎ）基因之表現抑制核酸分子、成骨細胞特異因子基因之表現抑制方法及其用途
EP2857513A4 (en) * 2012-05-26 2016-05-25 Bonac Corp Single-stranded nucleic acid molecule controlling the expression of a gene transporter
EP3088524A4 (en) 2013-12-26 2017-08-09 Tokyo Medical University Artificial mimic mirna for controlling gene expression, and use of same
BR112016014986A2 (pt) 2013-12-27 2018-01-23 Bonac Corporation mirna tipo correspondência artificial, composição e método para suprimir expressão de um gene alvo, composição farmacêutica, método para tratar uma doença, e, ácido nucleico de fita única
US10337009B2 (en) 2014-12-15 2019-07-02 Bonac Corporation Single-stranded nucleic acid molecule for inhibiting TGF-β1 expression
EP3239297B1 (en) 2014-12-27 2021-03-10 Bonac Corporation Naturally occuring mirna for controlling gene expression, and use of same
JP6602847B2 (ja) 2015-03-27 2019-11-06 株式会社ボナック デリバリー機能と遺伝子発現制御能を有する一本鎖核酸分子
MX2018005146A (es) * 2015-10-30 2018-08-23 Bonac Corp Composicion que contiene de manera estable molecula de acido nucleico de un solo filamento que suprime la expresion de gen tgf-b1.
BR112018013323A2 (pt) * 2015-12-29 2018-12-11 National University Corporation Hokkaido University molécula de ácido nucleico, inibidor de expressão, medicamento, agente terapêutico, método para inibir expressão de um gene pró-renina ou um gene receptor pró-renina, e, uso de uma molécula de ácido nucleico.
EP3409776A4 (en) 2016-01-30 2019-12-25 Bonac Corporation ARTIFICIAL SINGLE GUIDE RNA AND THEIR USE
WO2018182008A1 (ja) 2017-03-31 2018-10-04 株式会社ボナック 遺伝子発現制御機能を有する環状型核酸分子
WO2018199338A1 (ja) * 2017-04-27 2018-11-01 国立大学法人広島大学 Ｂ型肝炎治療用核酸分子
CN110996969B (zh) 2017-07-28 2023-02-28 杏林制药株式会社 纤维化疾病治疗剂
WO2019051563A1 (en) * 2017-09-15 2019-03-21 Commonwealth Scientific And Industrial Research Organisation Rna molecules
US11298371B2 (en) 2017-10-11 2022-04-12 Nitto Denko Corporation Regulation of nucleic acid molecule expression
WO2019074110A1 (ja) 2017-10-13 2019-04-18 株式会社ボナック 一本鎖核酸分子およびその製造方法
TWI830718B (zh) * 2018-02-09 2024-02-01 日商住友化學股份有限公司 核酸分子之製造方法
EP3778914A4 (en) 2018-03-30 2022-01-19 Sumitomo Chemical Company, Ltd. Method for producing single-strand rna
CN111819280A (zh) 2018-03-30 2020-10-23 东丽株式会社 发夹型单链rna分子的制备方法
CN112673102A (zh) * 2018-10-02 2021-04-16 东丽株式会社 发夹型单链rna分子的制备方法
JP7241098B2 (ja) 2019-01-25 2023-03-16 杏林製薬株式会社 線維症治療剤
KR20220079832A (ko) 2019-10-11 2022-06-14 스미또모 가가꾸 가부시끼가이샤 핵산 올리고머의 제조 방법
US20230312635A1 (en) 2020-01-29 2023-10-05 Sumitomo Chemical Company, Limited Method for producing nucleic acid oligomer
KR20220133919A (ko) 2020-01-29 2022-10-05 스미또모 가가꾸 가부시끼가이샤 핵산 올리고머의 제조 방법
JP7613130B2 (ja) * 2020-03-25 2025-01-15 味の素株式会社 リガーゼ変異体
KR20220160010A (ko) 2020-03-27 2022-12-05 스미또모 가가꾸 가부시끼가이샤 핵산 올리고머의 제조 방법
CN115867559A (zh) 2020-07-09 2023-03-28 住友化学株式会社 核酸寡聚物的制造方法
KR20230074205A (ko) 2020-09-24 2023-05-26 스미또모 가가꾸 가부시끼가이샤 핵산 올리고머의 제조 방법
EP4410770A1 (en) 2021-09-28 2024-08-07 Sumitomo Chemical Company, Limited Production method for purified dichloroacetic acid
KR20240162536A (ko) 2022-03-23 2024-11-15 스미또모 가가꾸 가부시끼가이샤 핵산 올리고머의 제조 방법
JP7201190B1 (ja) 2022-06-03 2023-01-10 株式会社セツロテック 遺伝子改変動物由来の動物繊維
KR20250092173A (ko) 2022-10-27 2025-06-23 스미또모 가가꾸 가부시끼가이샤 올리고뉴클레오티드의 제조 방법

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
US5631148A (en) * 1994-04-22 1997-05-20 Chiron Corporation Ribozymes with product ejection by strand displacement
US6509323B1 (en) 1998-07-01 2003-01-21 California Institute Of Technology Linear cyclodextrin copolymers
FR2790757B1 (fr) * 1999-03-09 2003-08-01 Bioalliance Pharma Oligonucleotides contenant une sequence antisens stabilises par une structure secondaire et compositions pharmaceutiques les contenant.
TWI321054B (en) 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
WO2003072745A2 (en) * 2002-02-22 2003-09-04 Eshleman James R Antigene locks and therapeutic uses thereof
EP1857547B2 (en) * 2002-08-05 2020-12-02 Silence Therapeutics GmbH Further novel forms of interfering RNA molecules
US20040058886A1 (en) * 2002-08-08 2004-03-25 Dharmacon, Inc. Short interfering RNAs having a hairpin structure containing a non-nucleotide loop
AU2004276684A1 (en) * 2003-09-30 2005-04-07 Anges Mg, Inc. Staple type oligonucleotide and drug comprising the same
AU2005327517B2 (en) * 2004-06-30 2011-05-26 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising a non-phosphate backbone linkage
WO2006074108A2 (en) * 2004-12-30 2006-07-13 Hauser Todd M Compositions and methods for modulating gene expression using self-protected oligonucleotides
WO2007108621A1 (en) * 2006-03-17 2007-09-27 Bioneer Corporation Sirna for inhibiting nf-kb/rela expression
JP5296328B2 (ja) * 2007-05-09 2013-09-25 独立行政法人理化学研究所 １本鎖環状ｒｎａおよびその製造方法
CN101889087B (zh) * 2007-11-29 2013-04-03 苏州瑞博生物技术有限公司 一种干扰靶基因表达的复合分子及其制备方法
US20110159586A1 (en) * 2007-12-07 2011-06-30 Halo-Bio Rnai Therapeutics, Inc. Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides
JP5540312B2 (ja) * 2008-02-15 2014-07-02 独立行政法人理化学研究所 環状１本鎖核酸複合体およびその製造方法
JP5187580B2 (ja) 2008-12-26 2013-04-24 丸紅建材リース株式会社 掘削機の泥土飛散防止装置
JP2010174915A (ja) 2009-01-27 2010-08-12 Toyota Motor Corp 高圧ガスタンク
JP5449815B2 (ja) 2009-03-26 2014-03-19 住友化学株式会社 偏光板の製造方法
JP5233790B2 (ja) 2009-03-26 2013-07-10 船井電機株式会社 液晶モジュール
JP2010269823A (ja) 2009-05-21 2010-12-02 British American Tobacco Japan Kk 喫煙品用容器
JP4885255B2 (ja) 2009-05-21 2012-02-29 株式会社エフピコ 包装用容器

Also Published As

Publication number Publication date
ES2670017T3 (es) 2018-05-29
JP4968811B2 (ja) 2012-07-04
EP2431466A1 (en) 2012-03-21
MX352568B (es) 2017-11-29
DK2933333T3 (en) 2018-04-30
AU2011274854A1 (en) 2013-02-14
MX2013000315A (es) 2013-05-01
CN102918156B (zh) 2015-11-25
CA2804511A1 (en) 2012-01-12
CA2804511C (en) 2021-07-06
PT2431466E (pt) 2016-01-08
EP2933333A1 (en) 2015-10-21
RU2628311C2 (ru) 2017-08-15
TWI573870B (zh) 2017-03-11
JP2015231381A (ja) 2015-12-24
TW201217523A (en) 2012-05-01
CN102918156A (zh) 2013-02-06
RU2013105329A (ru) 2014-08-20
WO2012005368A1 (ja) 2012-01-12
EP2431466B1 (en) 2015-10-07
JP6162182B2 (ja) 2017-07-12
EP2431466A4 (en) 2012-04-25
TW201627500A (zh) 2016-08-01
HK1181423A1 (zh) 2013-11-08
KR20130090792A (ko) 2013-08-14
EP2933333B1 (en) 2018-02-21
HUE026520T2 (en) 2016-06-28
TWI527901B (zh) 2016-04-01
SG196779A1 (en) 2014-02-13
BR112013000481A2 (pt) 2019-10-15
JP5804642B2 (ja) 2015-11-04
JPWO2012005368A1 (ja) 2013-09-05
HUE037500T2 (hu) 2018-08-28
AU2011274854B2 (en) 2015-04-16
NZ704812A (en) 2017-01-27
KR101849798B1 (ko) 2018-04-17
CN104818276B (zh) 2020-12-11
PT2933333T (pt) 2018-04-24
SG186899A1 (en) 2013-02-28
ES2550487T3 (es) 2015-11-10
CN104818276A (zh) 2015-08-05
DK2431466T3 (en) 2016-01-11
JP2012130342A (ja) 2012-07-12

Similar Documents

Publication Publication Date Title
NZ606232A (en) Single-stranded nucleic acid molecule for controlling gene expression
EP2639307A8 (en) Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton
WO2013032850A3 (en) Compositions and methods for high fidelity assembly of nucleic acids
CA2792561C (en) Compositions and methods for inhibiting expression of cd274/pd-l1 gene
NZ630591A (en) Microrna compounds and methods for modulating mir-21 activity
WO2014059356A3 (en) Selective antisense compounds and uses thereof
GB201010589D0 (en) Method and device
WO2017037304A3 (en) An assembly system for a eukaryotic cell
SG11201806372UA (en) Nucleic acid conjugate
NZ607870A (en) Lactococcus crispr-cas sequences
EP3418386A3 (en) Compositions and methods for inhibiting gene expression of hepatitis b virus
MX2021015290A (es) Composiciones y metodos para inhibicion de genes para apolipoproteina c-iii (apoc3).
MX356625B (es) Oligonucleotidos para elaborar un cambio en la secuencia de una molécula de ácido ribonucleico objetivo presente en una célula viva.
WO2010141511A3 (en) Polynucleotides for multivalent rna interference, compositions and methods of use thereof
EP3633038A3 (en) Modulation of dystrophia myotonica-protein kinase (dmpk) expression
WO2013155204A3 (en) Compositions and methods for inhibiting expression of the alas1 gene
WO2008116860A3 (en) Dsrna compositions and methods for treating hpv infections
HK1203075A1 (en) Substituted phosphorothioate nucleotide analogs
MX356792B (es) Elementos de regulacion de plantas y sus usos.
WO2012079046A3 (en) Compositions and methods for inhibiting expression of klf-1 and bcl11a genes
IN2014DN05665A (cg-RX-API-DMAC7.html)
AU2011230496A8 (en) Methods for enhancing nucleic acid hybridization
WO2013177248A3 (en) Modulation of enhancer rna mediated gene expression
MX2022006748A (es) Composiciones de acidos nucleicos.
WO2011054939A3 (en) Compositions and methods for inhibiting expression of kif10 genes

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 08 JUL 2018 BY PATENT + TRADE MARK RENEWAL SERVICES LTD

Effective date: 20151216

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2019 BY CPA GLOBAL

Effective date: 20180531

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2020 BY CPA GLOBAL

Effective date: 20190530

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2021 BY CPA GLOBAL

Effective date: 20200529

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2022 BY CPA GLOBAL

Effective date: 20210527

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 08 JUL 2023 BY CPA GLOBAL

Effective date: 20220607

LAPS Patent lapsed